Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Ossama El-Kabbani
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Concepts & Ideas
Procedures
Physiology
Genes & Molecular Sequences
Phenomena
Living Beings
Sign-in to see full Profile
Network (preview)
22
Hara, Akira
17
Ishikura, Shuhei
15
Darmanin, Connie
15
Endo, Satoshi
13
Matsunaga, Toshiyuki
12
Chung, Roland P-T
12
Carbone, Vincenzo
11
Tajima, Kazuo
9
Podjarny, Alberto
8
Flynn, Geoffrey
7
Delucas, Lawrence
7
Usami, Noriyuki
6
Hara, Akira
5
Carper, Deborah
5
Schulze-Briese, Clemens
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Ossama El-Kabbani (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Matsunaga Toshiyuki; Endo Satoshi; Soda Midori; Zhao Hai-Tao; El-Kabbani Ossama; Tajima Kazuo; Hara Akira
Potent and selective inhibition of the tumor marker AKR1B10 by bisdemethoxycurcumin: probing the active site of the enzyme with molecular modeling and site-directed mutagenesis.
Biochemical and biophysical research communications 2009;389(1):128-32.
-
2009: Matsunaga Toshiyuki; Arakaki Marina; Kamiya Tetsuro; Endo Satoshi; El-Kabbani Ossama; Hara Akira
Involvement of an aldo-keto reductase (AKR1C3) in redox cycling of 9,10-phenanthrenequinone leading to apoptosis in human endothelial cells.
Chemico-biological interactions 2009;181(1):52-60.
-
2009: Endo Satoshi; Matsunaga Toshiyuki; Mamiya Hiroaki; Ohta Chisato; Soda Midori; Kitade Yukio; Tajima Kazuo; Zhao Hai-Tao; El-Kabbani Ossama; Hara Akira
Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids.
Archives of biochemistry and biophysics 2009;487(1):1-9.
-
2009: El-Kabbani Ossama; Scammells Peter J; Gosling Joshua; Dhagat Urmi; Endo Satoshi; Matsunaga Toshiyuki; Soda Midori; Hara Akira
Structure-guided design, synthesis, and evaluation of salicylic acid-based inhibitors targeting a selectivity pocket in the active site of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1).
Journal of medicinal chemistry 2009;52(10):3259-64.
-
2009: Zhao H-T; Endo S; Ishikura S; Chung R; Hogg P J; Hara A; El-Kabbani O
Structure/function analysis of a critical disulfide bond in the active site of L-xylulose reductase.
Cellular and molecular life sciences : CMLS 2009;66(9):1570-9.
-
2009: Chung Roland; Endo Satoshi; Hara Akira; El-Kabbani Ossama
Crystallization and preliminary X-ray analysis of a rat aldose reductase-like protein (AKR1B14).
Acta crystallographica. Section F, Structural biology and crystallization communications 2009;65(Pt 4):395-7.
-
2009: Dhagat Urmi; Endo Satoshi; Mamiya Hiroaki; Hara Akira; El-Kabbani Ossama
Structure of the G225P/G226P mutant of mouse 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) ternary complex: implications for the binding of inhibitor and substrate.
Acta crystallographica. Section D, Biological crystallography 2009;65(Pt 3):257-65.
-
2009: Endo Satoshi; Matsunaga Toshiyuki; Mamiya Hiroaki; Hara Akira; Kitade Yukio; Tajima Kazuo; El-Kabbani Ossama
Characterization of a rat NADPH-dependent aldo-keto reductase (AKR1B13) induced by oxidative stress.
Chemico-biological interactions 2009;178(1-3):151-7.
-
2009: Carbone Vincenzo; Zhao Hai-Tao; Chung Roland; Endo Satoshi; Hara Akira; El-Kabbani Ossama
Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
Bioorganic & medicinal chemistry 2009;17(3):1244-50.
-
2009: Endo Satoshi; Maeda Satoshi; Matsunaga Toshiyuki; Dhagat Urmi; El-Kabbani Ossama; Tanaka Nobutada; Nakamura Kazuo T; Tajima Kazuo; Hara Akira
Molecular determinants for the stereospecific reduction of 3-ketosteroids and reactivity towards all-trans-retinal of a short-chain dehydrogenase/reductase (DHRS4).
Archives of biochemistry and biophysics 2009;481(2):183-90.
-
2008: Endo Satoshi; Matsunaga Toshiyuki; Kitade Yukio; Ohno Satoshi; Tajima Kazuo; El-Kabbani Ossama; Hara Akira
Human carbonyl reductase 4 is a mitochondrial NADPH-dependent quinone reductase.
Biochemical and biophysical research communications 2008;377(4):1326-30.
-
2008: Carbone Vincenzo; Chung Roland; Endo Satoshi; Hara Akira; El-Kabbani Ossama
Structure of aldehyde reductase in ternary complex with coenzyme and the potent 20alpha-hydroxysteroid dehydrogenase inhibitor 3,5-dichlorosalicylic acid: implications for inhibitor binding and selectivity.
Archives of biochemistry and biophysics 2008;479(1):82-7.
-
2008: Dhagat Urmi; Endo Satoshi; Sumii Rie; Hara Akira; El-Kabbani Ossama
Selectivity determinants of inhibitor binding to human 20alpha-hydroxysteroid dehydrogenase: crystal structure of the enzyme in ternary complex with coenzyme and the potent inhibitor 3,5-dichlorosalicylic acid.
Journal of medicinal chemistry 2008;51(15):4844-8.
-
2008: Carbone Vincenzo; Sumii Rie; Ishikura Shuhei; Asada Yukuhiko; Hara Akira; El-Kabbani Ossama
Structure of monkey dimeric dihydrodiol dehydrogenase in complex with isoascorbic acid.
Acta crystallographica. Section D, Biological crystallography 2008;64(Pt 5):532-42.
-
2008: Stefek Milan; Snirc Vladimir; Djoubissie Paul-Omer; Majekova Magdalena; Demopoulos Vassilis; Rackova Lucia; Bezakova Zelmira; Karasu Cimen; Carbone Vincenzo; El-Kabbani Ossama
Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
Bioorganic & medicinal chemistry 2008;16(9):4908-20.
-
2008: Carbone V; Hara A; El-Kabbani O
Structural and functional features of dimeric dihydrodiol dehydrogenase.
Cellular and molecular life sciences : CMLS 2008;65(10):1464-74.
-
2008: Zhao Hai-Tao; Hazemann Isabelle; Mitschler Andre; Carbone Vincenzo; Joachimiak Andrzej; Ginell Steve; Podjarny Alberto; El-Kabbani Ossama
Unusual binding mode of the 2S4R stereoisomer of the potent aldose reductase cyclic imide inhibitor fidarestat (2S4S) in the 15 K crystal structure of the ternary complex refined at 0.78 A resolution: implications for the inhibition mechanism.
Journal of medicinal chemistry 2008;51(5):1478-81.
-
2008: Dhagat Urmi; Endo Satoshi; Hara Akira; El-Kabbani Ossama
Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors.
Bioorganic & medicinal chemistry 2008;16(6):3245-54.
-
2008: Carbone Vincenzo; Endo Satoshi; Sumii Rie; Chung Roland P-T; Matsunaga Toshiyuki; Hara Akira; El-Kabbani Ossama
Structures of dimeric dihydrodiol dehydrogenase apoenzyme and inhibitor complex: probing the subunit interface with site-directed mutagenesis.
Proteins 2008;70(1):176-87.
-
2007: Dhagat Urmi; Carbone Vincenzo; Chung Roland P-T; Matsunaga Toshihiro; Endo Satoshi; Hara Akira; El-Kabbani Ossama
A salicylic acid-based analogue discovered from virtual screening as a potent inhibitor of human 20alpha-hydroxysteroid dehydrogenase.
Medicinal chemistry (Shariqah (United Arab Emirates)) 2007;3(6):546-50.
-
2007: Endo Satoshi; Sanai Masaharu; Horie Kenji; Matsunaga Toshiyuki; Ishikura Shuhei; Tajima Kazuo; El-Kabbani Ossama; Hara Akira
Characterization of rat and mouse NAD+-dependent 3alpha/17beta/20alpha-hydroxysteroid dehydrogenases and identification of substrate specificity determinants by site-directed mutagenesis.
Archives of biochemistry and biophysics 2007;467(1):76-86.
-
2007: Dhagat Urmi; Carbone Vincenzo; Chung Roland P-T; Schulze-Briese Clemens; Endo Satoshi; Hara Akira; El-Kabbani Ossama
Structure of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) holoenzyme from an orthorhombic crystal form: an insight into the bifunctionality of the enzyme.
Acta crystallographica. Section F, Structural biology and crystallization communications 2007;63(Pt 10):825-30.
-
2007: Endo Satoshi; Matsunaga Toshiyuki; Horie Kenji; Tajima Kazuo; Bunai Yasuo; Carbone Vincenzo; El-Kabbani Ossama; Hara Akira
Enzymatic characteristics of an aldo-keto reductase family protein (AKR1C15) and its localization in rat tissues.
Archives of biochemistry and biophysics 2007;465(1):136-47.
-
2007: El-Kabbani O; Podjarny A
Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites.
Cellular and molecular life sciences : CMLS 2007;64(15):1970-8.
-
2007: Sanai Masaharu; Endo Satoshi; Matsunaga Toshiyuki; Ishikura Shuhei; Tajima Kazuo; El-Kabbani Ossama; Hara Akira
Rat NAD+-dependent 3alpha-hydroxysteroid dehydrogenase (AKR1C17): a member of the aldo-keto reductase family highly expressed in kidney cytosol.
Archives of biochemistry and biophysics 2007;464(1):122-9.
-
2007: Fenalti Gustavo; Law Ruby H P; Buckle Ashley M; Langendorf Christopher; Tuck Kellie; Rosado Carlos J; Faux Noel G; Mahmood Khalid; Hampe Christiane S; Banga J Paul; Wilce Matthew; Schmidberger Jason; Rossjohn Jamie; El-Kabbani Ossama; Pike Robert N; Smith A Ian; Mackay Ian R; Rowley Merrill J; Whisstock James C
GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop.
Nature structural & molecular biology 2007;14(4):280-6.
-
2007: Fenalti Gustavo; Hampe Christiane S; O'connor Karen; Banga J Paul; Mackay Ian R; Rowley Merrill J; El-Kabbani Ossama
Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11.
Molecular immunology 2007;44(6):1178-89.
-
2006: Endo Satoshi; Matsumoto Kengo; Matsunaga Toshiyuki; Ishikura Shuhei; Tajima Kazuo; El-Kabbani Ossama; Hara Akira
Substrate specificity of a mouse aldo-keto reductase (AKR1C12).
Biological & pharmaceutical bulletin 2006;29(12):2488-92.
-
2006: Ishikura Shuhei; Matsumoto Kengo; Sanai Masaharu; Horie Kenji; Matsunaga Toshiyuki; Tajima Kazuo; El-Kabbani Ossama; Hara Akira
Molecular cloning of a novel type of rat cytoplasmic 17beta-hydroxysteroid dehydrogenase distinct from the type 5 isozyme.
Journal of biochemistry 2006;139(6):1053-63.
-
2006: Darmanin Connie; Iwata Takeshi; Carper Deborah A; El-Kabbani Ossama
Discovery of potential sorbitol dehydrogenase inhibitors from virtual screening.
Medicinal chemistry (Shariqah (United Arab Emirates)) 2006;2(3):239-42.
-
2006: O'Connor Karen H; Banga J Paul; Darmanin Connie; El-Kabbani Ossama; Mackay Ian R; Rowley Merrill J
Characterisation of an autoreactive conformational epitope on GAD65 recognised by the human monoclonal antibody b78 using a combination of phage display, in vitro mutagenesis and molecular modelling.
Journal of autoimmunity 2006;26(3):172-81.
-
2006: Matsumoto Kengo; Endo Satoshi; Ishikura Shuhei; Matsunaga Toshiyuki; Tajima Kazuo; El-Kabbani Ossama; Hara Akira
Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family.
Biological & pharmaceutical bulletin 2006;29(3):539-42.
-
2005: Petrova Tatiana; Steuber Holger; Hazemann Isabelle; Cousido-Siah Alexandra; Mitschler Andre; Chung Roland; Oka Mitsuru; Klebe Gerhard; El-Kabbani Ossama; Joachimiak Andrzej; Podjarny Alberto
Factorizing selectivity determinants of inhibitor binding toward aldose and aldehyde reductases: structural and thermodynamic properties of the aldose reductase mutant Leu300Pro-fidarestat complex.
Journal of medicinal chemistry 2005;48(18):5659-65.
-
2005: El-Kabbani Ossama; Carbone Vincenzo; Darmanin Connie; Oka Mitsuru; Mitschler Andre; Podjarny Alberto; Schulze-Briese Clemens; Chung Roland P-T
Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
Journal of medicinal chemistry 2005;48(17):5536-42.
-
2005: El-Kabbani Ossama; Carbone Vincenzo; Darmanin Connie; Ishikura Syuhei; Hara Akira
Structure of the tetrameric form of human L-Xylulose reductase: probing the inhibitor-binding site with molecular modeling and site-directed mutagenesis.
Proteins 2005;60(3):424-32.
-
2005: El-Kabbani Ossama; Ishikura Syuhei; Wagner Armin; Schulze-Briese Clemens; Hara Akira
Crystallization and preliminary X-ray diffraction analysis of mouse 3(17)alpha-hydroxysteroid dehydrogenase.
Acta crystallographica. Section F, Structural biology and crystallization communications 2005;61(Pt 7):688-90.
-
2005: Carbone Vincenzo; Ishikura Syuhei; Hara Akira; El-Kabbani Ossama
Structure-based discovery of human L-xylulose reductase inhibitors from database screening and molecular docking.
Bioorganic & medicinal chemistry 2005;13(2):301-12.
-
2004: Ishikura Syuhei; Usami Noriyuki; Nakajima Satoko; Kameyama Akiko; Shiraishi Hiroaki; Carbone Vincenzo; El-Kabbani Ossama; Hara Akira
Characterization of two isoforms of mouse 3(17)alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase family.
Biological & pharmaceutical bulletin 2004;27(12):1939-45.
-
2004: El-Kabbani Ossama; Darmanin Connie; Oka Mitsuru; Schulze-Briese Clemens; Tomizaki Takashi; Hazemann Isabelle; Mitschler Andre; Podjarny Alberto
High-resolution structures of human aldose reductase holoenzyme in complex with stereoisomers of the potent inhibitor Fidarestat: stereospecific interaction between the enzyme and a cyclic imide type inhibitor.
Journal of medicinal chemistry 2004;47(18):4530-7.
-
2004: Darmanin Connie; Chevreux Guillaume; Potier Noelle; Van Dorsselaer Alain; Hazemann Isabelle; Podjarny Alberto; El-Kabbani Ossama
Probing the ultra-high resolution structure of aldose reductase with molecular modelling and noncovalent mass spectrometry.
Bioorganic & medicinal chemistry 2004;12(14):3797-806.
-
2004: El-Kabbani Ossama; Darmanin Connie; Schneider Thomas R; Hazemann Isabelle; Ruiz Federico; Oka Mitsuru; Joachimiak Andrzejj; Schulze-Briese Clemens; Tomizaki Takashi; Mitschler Andre; Podjarny Alberto
Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors.
Proteins 2004;55(4):805-13.
-
2004: El-Kabbani Ossama; Ishikura Shuhei; Darmanin Connie; Carbone Vincenzo; Chung Roland P-T; Usami Noriyuki; Hara Akira
Crystal structure of human L-xylulose reductase holoenzyme: probing the role of Asn107 with site-directed mutagenesis.
Proteins 2004;55(3):724-32.
-
2004: El-Kabbani O; Ruiz F; Darmanin C; Chung R P-T
Aldose reductase structures: implications for mechanism and inhibition.
Cellular and molecular life sciences : CMLS 2004;61(7-8):750-62.
-
2004: El-Kabbani O; Darmanin C; Chung R P-T
Sorbitol dehydrogenase: structure, function and ligand design.
Current medicinal chemistry 2004;11(4):465-76.
-
2003: Myers Mark A; Fenalti Gustavo; Gray Robyn; Scealy Marita; Tong Jonathan C; El-Kabbani Ossama; Rowley Merrill J
A diabetes-related epitope of GAD65: a major diabetes-related conformational epitope on GAD65.
Annals of the New York Academy of Sciences 2003;1005():250-2.
-
2003: Ishikura Shuhei; Usami Noriyuki; El-Kabbani Ossama; Hara Akira
Structural determinant for cold inactivation of rodent L-xylulose reductase.
Biochemical and biophysical research communications 2003;308(1):68-72.
-
2003: Carbone Vincenzo; Darmanin Connie; Ishikura Shuhei; Hara Akira; El-Kabbani Ossama
Structure-based design of inhibitors of human L-xylulose reductase modelled into the active site of the enzyme.
Bioorganic & medicinal chemistry letters 2003;13(8):1469-74.
-
2003: Darmanin Connie; Iwata Takeshi; Carper Deborah A; Sparrow Lindsay G; Chung Roland P T; El-Kabbani Ossama
Expression, purification and preliminary crystallographic analysis of human sorbitol dehydrogenase.
Acta crystallographica. Section D, Biological crystallography 2003;59(Pt 3):558-60.
-
2003: Ishikura Shuhei; Isaji Tomoya; Usami Noriyuki; Nakagawa Junichi; El-Kabbani Ossama; Hara Akira
Identification of amino acid residues involved in substrate recognition of L-xylulose reductase by site-directed mutagenesis.
Chemico-biological interactions 2003;143-144():543-50.
-
2003: Higaki Yu; Usami Noriyuki; Shintani Syunichi; Ishikura Shuhei; El-Kabbani Ossama; Hara Akira
Selective and potent inhibitors of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone.
Chemico-biological interactions 2003;143-144():503-13.
-
2003: El-Kabbani Ossama; Ramsland Paul; Darmanin Connie; Chung Roland P-T; Podjarny Alberto
Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme.
Proteins 2003;50(2):230-8.
-
2002: El-Kabbani Ossama; Chung Roland P T; Ishikura Syuhei; Usami Noriyuki; Nakagawa Junichi; Hara Akira
Crystallization and preliminary crystallographic analysis of human L-xylulose reductase.
Acta crystallographica. Section D, Biological crystallography 2002;58(Pt 8):1379-80.
-
2002: El-Kabbani Ossama; Chung Roland P T; Ramsland Paul A; Asada Yukuhiko; Ishikura Syuhei; Usami Noriyuki; Hara Akira
Crystallization and preliminary X-ray diffraction analysis of monkey dimeric dihydrodiol dehydrogenase.
Acta crystallographica. Section D, Biological crystallography 2002;58(Pt 1):163-4.
-
2001: Darmanin C; El-Kabbani O
Modelling studies of the active site of human sorbitol dehydrogenase: an approach to structure-based inhibitor design of the enzyme.
Bioorganic & medicinal chemistry letters 2001;11(24):3133-6.
-
2000: El-Kabbani O; Rogniaux H; Barth P; Chung R P; Fletcher E V; Van Dorsselaer A; Podjarny A
Aldose and aldehyde reductases: correlation of molecular modeling and mass spectrometric studies on the binding of inhibitors to the active site.
Proteins 2000;41(3):407-14.
-
2000: Darmanin C; El-Kabbani O
Modelling studies on the binding of substrate and inhibitor to the active site of human sorbitol dehydrogenase.
Bioorganic & medicinal chemistry letters 2000;10(10):1101-4.
-
1999: El-Kabbani O; Old S E; Ginell S L; Carper D A
Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites.
Molecular vision 1999;5():20.
-
1998: Hohman T C; El-Kabbani O; Malamas M S; Lai K; Putilina T; McGowan M H; Wane Y Q; Carper D A
Probing the inhibitor-binding site of aldose reductase with site-directed mutagenesis.
European journal of biochemistry / FEBS 1998;256(2):310-6.
-
1998: El-Kabbani O; Wilson D K; Petrash M; Quiocho F A
Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
Molecular vision 1998;4():19.
-
1998: Rees-Milton K J; Jia Z; Green N C; Bhatia M; El-Kabbani O; Flynn T G
Aldehyde reductase: the role of C-terminal residues in defining substrate and cofactor specificities.
Archives of biochemistry and biophysics 1998;355(2):137-44.
-
1997: el-Kabbani O; Carper D A; McGowan M H; Devedjiev Y; Rees-Milton K J; Flynn T G
Studies on the inhibitor-binding site of porcine aldehyde reductase: crystal structure of the holoenzyme-inhibitor ternary complex.
Proteins 1997;29(2):186-92.
-
1995: el-Kabbani O; Judge K; Ginell S L; Myles D A; DeLucas L J; Flynn T G
Structure of porcine aldehyde reductase holoenzyme.
Nature structural biology 1995;2(8):687-92.
-
1995: El-Kabbani O; Judge K; Ginell S L; DeLucas L J; Flynn T G
Crystallization and preliminary structure of porcine aldehyde reductase-NADPH binary complex.
Acta crystallographica. Section D, Biological crystallography 1995;51(Pt 4):605-8.
-
1995: Flynn T G; Green N C; Bhatia M B; el-Kabbani O
Structure and mechanism of aldehyde reductase.
Advances in experimental medicine and biology 1995;372():193-201.
-
1994: El-Kabbani O; Green N C; Lin G; Carson M; Narayana S V; Moore K M; Flynn T G; DeLucas L J
Structures of human and porcine aldehyde reductase: an enzyme implicated in diabetic complications.
Acta crystallographica. Section D, Biological crystallography 1994;50(Pt 6):859-68.
-
1994: Narayana S V; Carson M; el-Kabbani O; Kilpatrick J M; Moore D; Chen X; Bugg C E; Volanakis J E; DeLucas L J
Structure of human factor D. A complement system protein at 2.0 A resolution.
Journal of molecular biology 1994;235(2):695-708.
-
1993: El-Kabbani O; Sthanam L; Narayana V L; Moore K M; Green N C; Flynn T G; Delucas L J
Crystallization and preliminary structure determination of porcine aldehyde reductase from two crystal forms.
Acta crystallographica. Section D, Biological crystallography 1993;49(Pt 5):490-6.
-
1991: Narayana S V; Kilpatrick J M; el-Kabbani O; Babu Y S; Bugg C E; Volanakis J E; DeLucas L J
Crystallization and preliminary X-ray investigation of factor D of human complement.
Journal of molecular biology 1991;219(1):1-3.
-
1991: el-Kabbani O; Narayana S V; Babu Y S; Moore K M; Flynn T G; Petrash J M; Westbrook E M; DeLucas L J; Bugg C E
Purification, crystallization and preliminary crystallographic analysis of porcine aldose reductase.
Journal of molecular biology 1991;218(4):695-8.
Sign-in to see more
